Biopharmaceutical company.
FY 2017 Budget Resolution (S. Con. Res. 3/H. Res. 48). H.R. 1628: H.R.1628 - American Health Care Act.

H.R. 749: Lower Drug Costs through Competition Act.

Education about the value of innovative new medicines.
BUD - Budget/Appropriations HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX